Follow US:
Over the past few years, biochemist John Jefferson Perry at the University of California, Riverside, has collaborated on a number of projects with Atomwise Inc., a company that uses artificial intelligence, or AI, for drug discovery. Now Perry and the company have formed a joint venture called Theia Biosciences. Perry’s...
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
UC Riverside research is supported by a four-year grant worth more than $1.2 million
UC Riverside and City of Hope awarded Department of Defense grants for the collaborative project
